Ryan Lim

Ryan Lim

brn

BRN: Neuromorphic AI Pioneer - First to Market, Last to Profit?

Updated 20 Oct 2025

Fair value $0.121 vs current $0.225 (47% overvalued). 95% revenue CAGR forecast, 79% customer concentration, 68% failure probability. Speculative growth only.

View note
al3

AL3: Defence AM Pioneer - Certified Success, Overpriced Reality

Updated 20 Oct 2025

Fair value $0.051 vs current $0.24 implies 79% downside. Strong defence positioning overwhelmed by extreme valuation and persistent cash burn through 2030.

View note
ppt

PPT: Financial Services Transformer - Simplification's the Salvation

Updated 20 Oct 2025

Fair value $20.62 vs current $20.90. Corporate Trust moat with 45%+ margins. J O Hambro turnaround critical. Expected 3-year returns 2.5% annually.

View note
dro

DRO: Counterdrone Specialist - Flying High, Landing Hard

Updated 20 Oct 2025

Pure-play counterdrone leader trading at $4.99 vs $2.59 fair value. Strong growth potential undermined by working capital crisis and 85% execution failure probability.

View note
bap

BAP: Automotive Aftermarket Leader - Transformation's Taking Time, But Value's Taking Shape

Updated 20 Oct 2025

Market-leading automotive distributor trading at 13% discount during operational transformation. Fair value $4.21 vs current $3.17 implies 33% upside with medium risk profile.

View note

Bapcor Limited (BAP) - Q1 FY26 Operational Update

Updated 20 Oct 2025

Alpha Insights Equity Research | 20 October 2025 Current Price: $3.17 | Updated Fair Value: $4.21 (previously $6.06) What Happened Bapcor's Q1 FY26 trading performance disappointed expectations with revenue declining 2.7% to $497.7 million year-on-year, marking the third consecutive quarter of operational challenges despite extensive

View note
xrf

XRF: Analytical Equipment Specialist - Peak Performance, Peak Peril

Updated 20 Oct 2025

Analytical equipment manufacturer trading at $2.12 vs $1.21 fair value. Strong Q1 growth but unsustainable 27.6% EBITDA margins face inevitable compression.

View note
fid

FID: Integrated Wealth Platform - Quality Execution Meets Transition Complexity

Updated 20 Oct 2025

Fiducian trades at $12.57 vs $11.84 fair value with 52.1% ROIC and 7.2/10 quality score, managing platform transformation amid legacy business decline

View note
ilu

ILU: Mineral Sands Giant - Crisis Management Meets Critical Minerals

Updated 17 Oct 2025

HOLD rating with $5.25 fair value vs $8.10 current price. Quality mining operation with validated crisis management and rare earths transformation potential.

View note
cyg

CYG: Industrial Distributor - Back to Basics, Forward to Profits

Updated 17 Oct 2025

Industrial distribution turnaround with $6.64 fair value vs $0.605 current price. Q1 EBITDA recovery validates $10m cost program. High risk, exceptional upside potential.

View note

Fenix Resources (FEX) - Q1 FY26 Operational Update

Updated 17 Oct 2025

Alpha Insights Equity Research | 17 October 2025 Current Price: A$0.52 | Updated Fair Value: A$1.65 (previously A$1.24) What Happened Fenix delivered transformational Q1 FY26 results demonstrating operational excellence whilst advancing strategic partnership with Baowu, the world's largest steel producer. Record quarterly iron ore

View note

Challenger Limited (CGF) - Q1 FY26 Operational Update

Updated 17 Oct 2025

Alpha Insights Equity Research | 17 October 2025 Current Price: $9.16 | Updated Fair Value: $10.77 (previously $12.23) What Happened Challenger delivered Q1 FY26 operational results demonstrating execution excellence across strategic priorities. Management reaffirmed FY26 guidance for 8-10% Life book growth despite challenging macro conditions, whilst strategic initiatives progressed

View note